J 2017

An anaplastic cardiac large cell lymphoma: A case report and analysis of cardiac involvement in newly diagnosed nonHodgkin’s lymphoma from the Czech Lymphoma Study Group (CLSG) database

LOBELLO, Cosimo, Andrea JANÍKOVÁ, Leoš KŘEN, Markéta HERMANOVÁ, Andrea ŠPRLÁKOVÁ-PUKOVÁ et. al.

Basic information

Original name

An anaplastic cardiac large cell lymphoma: A case report and analysis of cardiac involvement in newly diagnosed nonHodgkin’s lymphoma from the Czech Lymphoma Study Group (CLSG) database

Authors

LOBELLO, Cosimo (380 Italy, belonging to the institution), Andrea JANÍKOVÁ (203 Czech Republic, belonging to the institution), Leoš KŘEN (203 Czech Republic, belonging to the institution), Markéta HERMANOVÁ (203 Czech Republic, belonging to the institution), Andrea ŠPRLÁKOVÁ-PUKOVÁ (203 Czech Republic), Jan KREJČÍ (203 Czech Republic), Šárka POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution), Robert PYTLÍK (203 Czech Republic), Michaela HAMOUZOVÁ (203 Czech Republic), David BELADA (203 Czech Republic), Vit PROCHAZKA (203 Czech Republic), Juraj DURAS (203 Czech Republic), Heidi MÓCIKOVÁ (203 Czech Republic) and Marek TRNĚNÝ (203 Czech Republic)

Edition

Journal of Cancer Research & Therapy, Manchester, NobleResearch Publishers Limited, 2017, 2052-4994

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30201 Cardiac and Cardiovascular systems

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

RIV identification code

RIV/00216224:14110/17:00099922

Organization unit

Faculty of Medicine

Keywords in English

cardiac lymphoma; anaplastic large cell lymphoma; ALK

Tags

Změněno: 6/3/2018 15:46, Soňa Böhmová

Abstract

V originále

We report a rare case of anaplastic large cell ALK+ lymphoma (ALCL) with initial asymptomatic cardiac involvement. A 59-year-old male with infiltration of the right ventricular wall underwent standard combined chemotherapy (CHOP) and achieved remission without significant cardiac impairment. Additionally, we report the actual incidence of cardiac lymphoma in newly diagnosed non-Hodgkin Lymphomas (NHLs). In total, 16 patients with cardiac lymphoma were found (0.1% NHLs) in the Czech Lymphoma Study Group database. DLBCL was the most frequent histology subtype (50%), and ALCL was identified in 12.5% of cases. At initial diagnosis, the median age was 55.5 (range 21-74) years and 59% were men. None of the 16 patients with cardiac involvement had isolated heart lymphoma. The response to first-line therapy was 79% in 14/16 evaluable patients. The median progression-free survival and overall survival were nearly the same -approximately 3.5 years (range; 0.05-16.7ys), while the median follow up was 4 years.

Links

LQ1601, research and development project
Name: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR